|
PLBD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.45239999605718E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12410003527685E-09 |
| Normal-vs-Stage2 |
3.472000E-01 |
| Normal-vs-Stage3 |
2.481600E-03 |
| Normal-vs-Stage4 |
5.537200E-03 |
| Stage1-vs-Stage2 |
1.563870E-03 |
| Stage1-vs-Stage3 |
8.689600E-02 |
| Stage1-vs-Stage4 |
1.572800E-01 |
| Stage2-vs-Stage3 |
9.533900E-02 |
| Stage2-vs-Stage4 |
1.052610E-01 |
| Stage3-vs-Stage4 |
9.318600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09260000047406E-07 |
| Normal-vs-AfricanAmerican |
3.333700E-02 |
| Normal-vs-Asian |
6.546100E-02 |
| Caucasian-vs-AfricanAmerican |
4.074000E-01 |
| Caucasian-vs-Asian |
2.055400E-01 |
| AfricanAmerican-vs-Asian |
1.401750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98740000012521E-07 |
| Normal-vs-Female |
4.24060000000503E-05 |
| Male-vs-Female |
4.425800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.940300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.70360000018822E-07 |
| Normal-vs-Age(61-80Yrs) |
2.87629999995431E-06 |
| Normal-vs-Age(81-100Yrs) |
3.800800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.542800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.892800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.864800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.864400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.591000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.146400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.813540E-04 |
| Normal-vs-Grade 2 |
6.94120000033216E-07 |
| Normal-vs-Grade 3 |
1.032590E-04 |
| Normal-vs-Grade 4 |
6.627400E-04 |
| Grade 1-vs-Grade 2 |
2.370400E-01 |
| Grade 1-vs-Grade 3 |
1.395840E-01 |
| Grade 1-vs-Grade 4 |
7.143200E-01 |
| Grade 2-vs-Grade 3 |
5.335400E-01 |
| Grade 2-vs-Grade 4 |
4.535200E-01 |
| Grade 3-vs-Grade 4 |
2.797200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.164300E-04 |
| Normal-vs-ccB subtype |
9.61020041323479E-10 |
| ccA subtype-vs-ccB subtype |
8.372500000009E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1734000000293E-06 |
| Normal-vs-N1 |
7.555600E-02 |
| N0-vs-N1 |
4.815600E-01 |
|
|
